Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

280
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
280
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

369
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
369
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

590
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
590
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

248
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
248
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

215
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Case report: Subcutaneous emphysema following postoperative nausea.

SAGE open medical case reports·2026
Same author

Dental School Biopsy Education to Promote Access to Care and Early Detection.

Journal of dental education·2026
Same author

A Cold World: Pain Outcomes and Patient Experiences Utilizing an Iceless Cold Compression System After Hand Surgery.

Hand (New York, N.Y.)·2026
Same author

Septic Temporomandibular Joint.

The Journal of emergency medicine·2026
Same author

Sterilization of Stainless-Steel Surfaces Using Ultraviolet Radiation Produced by Light-Emitting Diodes.

Astrobiology·2025
Same author

A pediatric patient with mandibular swelling.

Journal of the American Dental Association (1939)·2025

Video Experimental Relacionado

Updated: Jan 18, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.5K

Ictus Isquémico Recurrente: Estrategias de Prevención

Brian Ford, Michael M Dore, Tyler R Koehn

    American family physician
    |January 16, 2026
    PubMed
    Resumen
    Este resumen es generado por máquina.

    La prevención de la recurrencia del ictus isquémico implica el manejo de los factores de riesgo cardiovascular y la adaptación de los tratamientos, como la anticoagulación o la terapia antiplaquetaria, según la causa del ictus. La detección e intervención tempranas son clave para reducir el riesgo de recurrencia del ictus a largo plazo.

    Palabras clave:
    ictus isquémico recurrenteprevención secundariafactores de riesgo cardiovascularterapia antiplaquetariaanticoagulantes

    Más Videos Relacionados

    Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
    09:48

    Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice

    Published on: May 4, 2015

    14.2K
    A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
    06:01

    A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

    Published on: August 18, 2015

    15.4K

    Videos de Experimentos Relacionados

    Last Updated: Jan 18, 2026

    Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
    09:21

    Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

    Published on: January 18, 2018

    12.5K
    Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
    09:48

    Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice

    Published on: May 4, 2015

    14.2K
    A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
    06:01

    A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

    Published on: August 18, 2015

    15.4K

    Área de la Ciencia:

    • Neurología; Cardiología; Salud Pública

    Sus antecedentes:

    • Los ictus isquémicos constituyen el 87% de todos los ictus agudos. Un significativo 12% de los pacientes experimentan recurrencia del ictus dentro de los 5 años, lo que resalta la necesidad de estrategias efectivas de prevención secundaria.

    Objetivo del estudio:

    • Esbozar las herramientas de diagnóstico para identificar las causas del ictus isquémico agudo. Detallar las estrategias de manejo para reducir el riesgo de recurrencia del ictus.

    Principales métodos:

    • Revisión de las directrices establecidas y las prácticas clínicas para el manejo del ictus. Identificación de los factores de riesgo clave y las intervenciones terapéuticas para la prevención secundaria del ictus.

    Principales resultados:

    • El manejo efectivo incluye el control de la hipertensión (objetivo 130/80 mm Hg), la terapia con estatinas, el control de la glucosa en sangre, modificaciones del estilo de vida (dieta, ejercicio, evitar el consumo de sustancias) y el tratamiento de la apnea del sueño. La selección del tratamiento es específica de la causa: anticoagulantes para el ictus embólico relacionado con la fibrilación auricular, terapia antiplaquetaria para el ictus no embólico. Pueden ser necesarias intervenciones procedimentales como el manejo de la estenosis carotídea o el cierre del foramen oval permeable. Son esenciales diagnósticos adicionales, incluido el monitoreo cardíaco a largo plazo para la fibrilación auricular, cuando la etiología del ictus no está clara.

    Conclusiones:

    • El manejo integral de los factores de riesgo cardiovascular es crucial para la prevención secundaria del ictus. Adaptar la terapia antitrombótica y considerar las intervenciones procedimentales según la causa del ictus mejora los resultados. La evaluación diagnóstica exhaustiva es vital para optimizar el tratamiento y reducir el riesgo de recurrencia en casos no claros.